Safety Study of NHL907 in Healthy Adults
This is an early-stage safety study testing a new drug called NHL907 in healthy volunteers. Researchers want to understand how the drug is processed by the body and confirm it is safe.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 18 and 60 years old and in good overall health
- Have a body mass index (BMI) between 18 and 32, and weigh at least 50 kg (110 lbs)
- Not be pregnant, nursing, or planning to become pregnant within 6 months after the study
- Not smoke, use nicotine products, or abuse drugs or alcohol
- Not take most other medications, supplements, or herbal remedies during the study
- Be able to have blood tests and comply with all study visits and procedures
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing a new medicine called KHN707 in healthy people. The goal is to see if it is safe and how the body handles it. It is an early-stage study, so it is not intended to treat any condition yet.
This is an early-stage safety test of a new investigational drug called HSK56630 in healthy volunteers with no major medical conditions. Researchers will monitor how your body tolerates the drug and what side effects might occur.
This is a Phase 1 safety study testing a new investigational drug in healthy volunteers with no serious medical conditions. Researchers will give some participants the drug and others a placebo (inactive treatment) to see how safe the drug is and how the body responds to it.
This study tests a new medicine in healthy people to see if it is safe and how the body handles it. Participating could help understand side effects before testing in patients.
This trial tests an investigational drug, HS-10542, in healthy adults to see how it is processed by the body and to check for side effects. You must be willing to receive two vaccines before the study starts.
This study tests a new oral medication, HY8931, in healthy adults to see if it is safe and how the body processes it. You will be closely monitored during the trial.
Hear when a new Healthy Adult Participants trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.